
Am J Psychiatry 163:2164-2169, December 2006
doi: 10.1176/appi.ajp.163.12.2164
© 2006 American Psychiatric Association
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
John G. Csernansky, M.D.,
Hongxin Dong, Ph.D.,
Anne M. Fagan, Ph.D.,
Lei Wang, Ph.D.,
Chengjie Xiong, Ph.D.,
David M. Holtzman, M.D., and
John C. Morris, M.D.
OBJECTIVE: Studies of subjects with dementia of the Alzheimer type have reported correlations between increases in activity of the hypothalamic-pituitary-adrenal (HPA) axis and hippocampal degeneration. In this study, the authors sought to determine whether increases in plasma cortisol, a marker of HPA activity, were associated with clinical and cognitive measures of the rate of disease progression in subjects with Alzheimer-type dementia. METHOD: Thirty-three subjects with very mild and mild Alzheimer-type dementia and 21 subjects without dementia were assessed annually for up to 4 years with the Clinical Dementia Rating scale and a battery of neuropsychological tests. Plasma was obtained at 8 a.m. on a single day and assayed for cortisol. Rates of change over time in the clinical and cognitive measures were derived from growth curve models. RESULTS: In the subjects with dementia, but not in those without dementia, higher plasma cortisol levels were associated with more rapidly increasing symptoms of dementia and more rapidly decreasing performance on neuropsychological tests associated with temporal lobe function. No associations were observed between plasma cortisol levels and clinical and cognitive assessments obtained at the single assessment closest in time to the plasma collection. CONCLUSIONS: Higher HPA activity, as reflected by increased plasma cortisol levels, is associated with more rapid disease progression in subjects with Alzheimer-type dementia.
This article has been cited by other articles:

|
 |

|
 |
 
O. T Wolf and B. M Kudielka
Stress, health and ageing: a focus on postmenopausal women
Menopause Int,
September 1, 2008;
14(3):
129 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. S. Tan, A. Beiser, R. S. Vasan, R. Au, S. Auerbach, D. P. Kiel, P. A. Wolf, and S. Seshadri
Thyroid Function and the Risk of Alzheimer Disease: The Framingham Study
Arch Intern Med,
July 28, 2008;
168(14):
1514 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Reyes-Ortiz, I. M. Berges, M. A. Raji, H. G. Koenig, Y.-F. Kuo, and K. S. Markides
Church Attendance Mediates the Association Between Depressive Symptoms and Cognitive Functioning Among Older Mexican Americans
J. Gerontol. A Biol. Sci. Med. Sci.,
May 1, 2008;
63(5):
480 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Lenze and B. H. Mulsant
Biomarkers in Geriatric Psychiatry
Am J Geriatr Psychiatry,
October 1, 2007;
15(10):
827 - 831.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-E. Kang, J. R. Cirrito, H. Dong, J. G. Csernansky, and D. M. Holtzman
Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity
PNAS,
June 19, 2007;
104(25):
10673 - 10678.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|